Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
North Star in Primary Hypothyroidism
NCT07747103Phase 3Recruiting
- Sponsor
- Neuvosyn Laboratories
- Start
- Jun 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 3 trial of North Star in primary hypothyroidism (PH), sponsored by Neuvosyn Laboratories. Started Jun 2026; status: recruiting.
02
Drugs
North Star
03
Conditions
primary hypothyroidism (PH)
Beyond the preview
Go deeper on NCT07747103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07747103.